Senseonics Holdings Inc (NYSEAMERICAN:SENS) CEO Timothy T. Goodnow purchased 88,500 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were acquired at an average cost of $1.10 per share, for a total transaction of $97,350.00.
Shares of Senseonics stock traded down $0.01 on Thursday, hitting $1.12. The stock had a trading volume of 38,559 shares, compared to its average volume of 1,812,573. Senseonics Holdings Inc has a one year low of $0.92 and a one year high of $4.89.
Senseonics (NYSEAMERICAN:SENS) last issued its earnings results on Wednesday, August 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.01). The firm had revenue of $4.61 million for the quarter, compared to analysts’ expectations of $4.53 million. During the same quarter last year, the company earned ($0.16) EPS. The business’s revenue was up 27.2% on a year-over-year basis.
SENS has been the topic of several research reports. Raymond James downgraded shares of Senseonics from an “outperform” rating to a “market perform” rating in a research note on Friday, July 5th. BTIG Research reissued a “buy” rating and set a $2.00 price target on shares of Senseonics in a research note on Sunday, August 11th. Finally, Piper Jaffray Companies set a $2.00 price target on shares of Senseonics and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. Senseonics currently has a consensus rating of “Hold” and a consensus target price of $2.00.
A number of large investors have recently added to or reduced their stakes in SENS. Bank of America Corp DE boosted its holdings in Senseonics by 620.3% in the fourth quarter. Bank of America Corp DE now owns 40,705 shares of the company’s stock valued at $106,000 after acquiring an additional 35,054 shares in the last quarter. Creative Planning bought a new stake in Senseonics in the first quarter valued at $34,000. BNP Paribas Arbitrage SA bought a new stake in Senseonics in the first quarter valued at $43,000. SG Americas Securities LLC bought a new stake in Senseonics in the first quarter valued at $46,000. Finally, Moors & Cabot Inc. bought a new stake in Senseonics in the first quarter valued at $38,000. Institutional investors and hedge funds own 30.66% of the company’s stock.
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Recommended Story: What are municipal bonds?
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.